Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Ocular blood vessels are the network of arteries and veins responsible for supplying blood to and draining blood from the structures of the eye. These vessels are essential for delivering oxygen and nutrients, removing metabolic waste, maintaining intraocular pressure, and supporting visual function. Damage or dysfunction of these vessels can lead to a variety of ocular diseases and vision loss.
Varies depending on the specific drug and disease. Anti-VEGF agents inhibit vascular endothelial growth factor, reducing angiogenesis. Antihypertensives lower blood pressure, protecting vessels from damage. Anti-diabetic medications control blood sugar, preventing diabetic retinopathy. Glaucoma medications reduce intraocular pressure, relieving pressure on vessels and optic nerve.
3 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Ocular Blood Vessels.